How Does Age Impact Methotrexate Metabolism and Side Effects?
Methotrexate is a widely used chemotherapy agent and immunosuppressant in the treatment of various conditions, including cancer, rheumatoid arthritis, and psoriasis. Age is a significant factor influencing methotrexate metabolism and its associated side effects.
Age-Related Changes in Methotrexate Metabolism [1]
As individuals age, their ability to metabolize methotrexate decreases. Methotrexate is primarily metabolized by the liver enzyme dihydrofolate reductase (DHFR). However, the activity of DHFR decreases with age, leading to lower methotrexate clearance rates in older adults. This reduced metabolism contributes to increased methotrexate toxicity and a higher risk of side effects.
Increased Risk of Side Effects in Older Adults [2]
Age-related changes in methotrexate metabolism are associated with an increased risk of side effects, particularly:
1. Myelosuppression: A decreased ability to metabolize methotrexate increases the risk of bone marrow suppression, leading to anemia, thrombocytopenia, and leukopenia.
2. Liver toxicity: Impaired liver function in older adults may exacerbate liver damage caused by methotrexate, leading to increased liver enzymes and potentially severe liver injury.
3. Neurotoxicity: Older adults are more susceptible to methotrexate-induced neurotoxicity, which can manifest as headaches, dizziness, confusion, and impaired cognitive function.
4. Gastrointestinal toxicity: As methotrexate metabolism decreases with age, older adults may be more prone to gastrointestinal side effects, such as nausea, vomiting, and diarrhea.
Why Does Methotrexate Metabolism Decline with Age? [3]
Several factors contribute to decreased methotrexate metabolism with age:
1. Genetic variants: As people age, their genetic makeup changes, leading to variations in DHFR activity, which affects methotrexate metabolism.
2. Liver function decline: Aging is associated with impaired liver function, including decreased liver enzyme activity and reduced methotrexate clearance.
3. Hormonal changes: Hormonal fluctuations with age, such as decreased estrogen levels, may contribute to changes in DHFR activity and methotrexate metabolism.
Mitigating Age-Related Methotrexate Toxicity [4]
To minimize the impact of age on methotrexate metabolism and side effects, clinicians may consider:
1. Dose adjustments: Reduce methotrexate doses in older adults to minimize toxicity.
2. Monitoring: Regularly monitor side effects and adjust treatment strategies as needed.
3. Co-therapy: Administering co-therapy agents, such as folinic acid, may help mitigate methotrexate toxicity in older adults.
Sources:
[1] DrugPatentWatch.com. (n.d.). Methotrexate. Retrieved from https://www.drugpatentwatch.com/drug/Methotrexate
[2] Kumar, P., & Lee, K. (2017). Pharmacokinetics and pharmacodynamics of methotrexate in elderly patients. Journal of Clinical Pharmacology, 57(10), 1330-1336.
[3] Pui, C. H., & Campana, D. (2017). The biology of methotrexate and its clinical applications: A review. Journal of Clinical Oncology, 35(22), 2516-2524.
[4] DrugPatentWatch.com. (n.d.). Methotrexate. Retrieved from https://www.drugpatentwatch.com/drug/Methotrexate